Lantz Financial
CL icon

Lantz Financial’s Colgate-Palmolive CL Stock Holding History

Lantz Financial’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.59M Buy
18,601
+35
+0.2% +$3.17K 0.29% 84
2026
Q2 		$1.7M Buy
18,566
+95
+0.5% +$8.31K 0.31% 88
2026
Q1 		$1.57M Sell
18,471
-883
-5% -$78.7K 0.33% 83
2025
Q4 		$1.53M Buy
19,354
+149
+0.8% +$11.7K 0.32% 85
2025
Q3 		$1.54M Buy
19,205
+3
+0% +$256 0.34% 85
2025
Q2 		$1.75M Sell
19,202
-83
-0.4% -$7.58K 0.44% 70
2025
Q1 		$1.81M Sell
19,285
-855
-4% -$76.6K 0.49% 60
2024
Q4 		$1.83M Buy
20,140
+122
+0.6% +$11.6K 0.49% 60
2024
Q3 		$2.08M Buy
20,018
+24
+0.1% +$2.45K 0.56% 54
2024
Q2 		$1.94M Sell
19,994
-56
-0.3% -$5.17K 0.6% 49
2024
Q1 		$1.81M Buy
20,050
+135
+0.7% +$11.4K 0.58% 54
2023
Q4 		$1.59M Buy
19,915
+801
+4% +$60.2K 0.57% 51
2023
Q3 		$1.36M Sell
19,114
-292
-2% -$21.8K 0.54% 54
2023
Q2 		$1.5M Sell
19,406
-38
-0.2% -$2.94K 0.59% 53
2023
Q1 		$1.46M Sell
19,444
-145
-0.7% -$10.8K 0.61% 50
2022
Q4 		$1.54M Buy
19,589
+317
+2% +$23.8K 0.7% 39
2022
Q3 		$1.35M Buy
19,272
+58
+0.3% +$4.55K 0.7% 39
2022
Q2 		$1.54M Buy
19,214
+75
+0.4% +$5.86K 0.7% 40
2022
Q1 		$1.45M Buy
19,139
+287
+2% +$22.7K 0.59% 52
2021
Q4 		$1.61M Buy
18,852
+778
+4% +$60.8K 0.74% 40
2021
Q3 		$1.37M Buy
18,074
+378
+2% +$30K 0.7% 43
2021
Q2 		$1.44M Buy
17,696
+27
+0.2% +$2.21K 0.74% 40
2021
Q1 		$1.39M Buy
17,669
+125
+0.7% +$9.8K 0.79% 38
2020
Q4 		$1.5M Sell
17,544
-268
-2% -$22.2K 0.94% 29
2020
Q3 		$1.37M Sell
17,812
-31
-0.2% -$2.36K 0.92% 33
2020
Q2 		$1.31M Sell
17,843
-425
-2% -$30.2K 0.94% 31
2020
Q1 		$1.21M Sell
18,268
-827
-4% -$58.3K 0.95% 31
2019
Q4 		$1.31M Buy
19,095
+220
+1% +$15K 0.78% 47
2019
Q3 		$1.33M Buy
18,875
+213
+1% +$15.5K 0.9% 36
2019
Q2 		$1.36M Buy
18,662
+436
+2% +$31K 0.92% 36
2019
Q1 		$1.25M Buy
+18,226
New +$1.18M 0.91% 39

Other funds holding CL

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
PineStone Asset Management
PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Lantz Financial's CL Position: Q3 2026 in Review

Lantz Financial increased its Colgate-Palmolive (CL) stake by 0.19% in Q3 2026, buying an estimated $3.17K and bringing the position to 18,601 shares worth $1.59M. The position accounts for 0.29% of the portfolio, ranked #84.

Lantz Financial first reported a position in CL in Q1 2019 and has held it in 31 quarters since. The position peaked at $2.08M in Q3 2024. 808 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Lantz Financial held 18,601 shares of Colgate-Palmolive worth $1.59M as of Q3 2026.
  • Lantz Financial bought 35 Colgate-Palmolive shares in Q3 2026, an estimated $3.17K.
  • Colgate-Palmolive made up 0.29% of Lantz Financial's portfolio in Q3 2026, its #84 holding.
  • Lantz Financial first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 31 quarters since.
  • Lantz Financial's Colgate-Palmolive position peaked at $2.08M in Q3 2024.
  • 808 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Lantz Financial's 13F filing for Q3 2026, filed 15 Oct 2026.